BTNA
BMY icon

Bremer Trust National Association’s Bristol-Myers Squibb BMY Stock Holding History

Bremer Trust National Association’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$2.08M Buy
39,920
+3,712
+10% +$199K 0.45% 55
2018
Q3 		$2.25M Buy
36,208
+7,231
+25% +$429K 0.56% 46
2018
Q2 		$1.6M Buy
28,977
+18,327
+172% +$990K 0.44% 61
2018
Q1 		$674K Sell
10,650
-59
-0.6% -$3.79K 0.19% 115
2017
Q4 		$656K Sell
10,709
-375
-3% -$23.5K 0.18% 124
2017
Q3 		$706K Sell
11,084
-558
-5% -$32.6K 0.2% 113
2017
Q2 		$648K Sell
11,642
-669
-5% -$36.4K 0.18% 117
2017
Q1 		$669K Sell
12,311
-6,948
-36% -$381K 0.18% 123
2016
Q4 		$1.13M Buy
19,259
+1,740
+10% +$95.1K 0.31% 92
2016
Q3 		$944K Sell
17,519
-3,627
-17% -$233K 0.26% 107
2016
Q2 		$1.55M Buy
21,146
+5,063
+31% +$358K 0.43% 68
2016
Q1 		$1.03M Buy
16,083
+3,616
+29% +$228K 0.3% 85
2015
Q4 		$857K Buy
12,467
+445
+4% +$29.4K 0.26% 93
2015
Q3 		$712K Sell
12,022
-4,551
-27% -$289K 0.23% 102
2015
Q2 		$1.1M Buy
16,573
+2,480
+18% +$163K 0.33% 79
2015
Q1 		$909K Sell
14,093
-2,237
-14% -$140K 0.29% 90
2014
Q4 		$964K Buy
16,330
+290
+2% +$16.4K 0.31% 86
2014
Q3 		$821K Buy
16,040
+1,181
+8% +$59K 0.28% 89
2014
Q2 		$721K Sell
14,859
-1,004
-6% -$49.5K 0.25% 93
2014
Q1 		$825K Sell
15,863
-926
-6% -$49.3K 0.3% 74
2013
Q4 		$892K Sell
16,789
-1,737
-9% -$88.5K 0.34% 67
2013
Q3 		$857K Sell
18,526
-2,124
-10% -$93.2K 0.36% 64
2013
Q2 		$923K Buy
+20,650
New +$897K 0.41% 58

Other funds holding BMY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bremer Trust National Association's BMY Position: Q4 2018 in Review

Bremer Trust National Association increased its Bristol-Myers Squibb (BMY) stake by 10% in Q4 2018, buying an estimated $199K and bringing the position to 39,920 shares worth $2.08M. The position accounts for 0.45% of the portfolio, ranked #55.

Bremer Trust National Association first reported a position in BMY in Q2 2013 and has held it in 23 quarters since. The position peaked at $2.25M in Q3 2018. 1,766 funds tracked by Wall St. Rank hold BMY as of Q4 2018.

  • Bremer Trust National Association held 39,920 shares of Bristol-Myers Squibb worth $2.08M as of Q4 2018.
  • Bremer Trust National Association bought 3,712 Bristol-Myers Squibb shares in Q4 2018, an estimated $199K.
  • Bristol-Myers Squibb made up 0.45% of Bremer Trust National Association's portfolio in Q4 2018, its #55 holding.
  • Bremer Trust National Association first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 23 quarters since.
  • Bremer Trust National Association's Bristol-Myers Squibb position peaked at $2.25M in Q3 2018.
  • 1,766 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2018.

Based on Bremer Trust National Association's 13F filing for Q4 2018, filed 11 Feb 2019.